Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nabriva Therapeutics AG
DescriptionTopical pleuromutilin antibiotic agent
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase I
Standard IndicationBacterial infection
Indication DetailsTreat bacterial infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today